In this study, we found that the ectopic expression of claudin-1 at the BBB significantly reduces BBB leakiness and the disease burden during the chronic phase of the disease and hence that BBB dysfunction is a potential key event that contibutes to clinical disease in the chronic phase of neuroinflammatory disorders such as MS. Here, CLDN1 is linked to myeloid sarcoma.